Table 2.
Sensitivity, specificity, NPV, and PPV of the determined cutoff values for diagnostic accuracy of galectin‐9 and CXCL10 in the juvenile dermatomyositis internal validation cohorta
Galectin‐9 | CXCL10 | |
---|---|---|
Cutoff value, pg/ml | 19,396 | 805 |
Sensitivity | 0.839 | 0.871 |
Specificity | 0.923 | 1.000 |
NPV | 0.828 | 0.867 |
PPV | 0.929 | 1.000 |
Cutoff values for galectin‐9 and CXCL10 were determined based on the maximal Youden's Index with a sensitivity of >0.80, in order to ensure a low risk of ongoing active inflammation with a biomarker value below the set cutoff. Only 1 sample per patient per category (active disease or in remission) was included in the analysis (i.e., the cohort designated “JDM NL” [Juvenile Dermatomyositis The Netherlands], as shown in Figure 2 and Supplementary Table 5 on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.40881/abstract]). NPV = negative predictive value; PPV = positive predictive value.